...
首页> 外文期刊>BMC Microbiology >Administration of two probiotic strains during early childhood does not affect the endogenous gut microbiota composition despite probiotic proliferation
【24h】

Administration of two probiotic strains during early childhood does not affect the endogenous gut microbiota composition despite probiotic proliferation

机译:尽管益生菌增殖,在幼儿期施用两种益生菌菌株不会影响内源性肠道菌群的组成

获取原文
           

摘要

Probiotics are increasingly applied to prevent and treat a range of infectious, immune related and gastrointestinal diseases. Despite this, the mechanisms behind the putative effects of probiotics are poorly understood. One of the suggested modes of probiotic action is modulation of the endogenous gut microbiota, however probiotic intervention studies in adults have failed to show significant effects on gut microbiota composition. The gut microbiota of young children is known to be unstable and more responsive to external factors than that of adults. Therefore, potential effects of probiotic intervention on gut microbiota may be easier detectable in early life. We thus investigated the effects of a 6 month placebo-controlled probiotic intervention with Bifidobacterium animalis subsp. lactis (BB-12®) and Lactobacillus rhamnosus (LGG®) on gut microbiota composition and diversity in more than 200 Danish infants (N = 290 enrolled; N = 201 all samples analyzed), as assessed by 16S rRNA amplicon sequencing. Further, we evaluated probiotic presence and proliferation by use of specific quantitative polymerase chain reaction (qPCR). Probiotic administration did not significantly alter gut microbiota community structure or diversity as compared to placebo. The probiotic strains were detected in 91.3% of the fecal samples from children receiving probiotics and in 1% of the placebo treated children. Baseline gut microbiota was not found to predict the ability of probiotics to establish in the gut after the 6 month intervention. Within the probiotics group, proliferation of the strains LGG® and BB-12® in the gut was detected in 44.7% and 83.5% of the participants, respectively. A sub-analysis of the gut microbiota including only individuals with detected growth of the probiotics LGG® or BB-12® and comparing these to placebo revealed no differences in community structure or diversity. Six months of probiotic administration during early life did not change gut microbiota community structure or diversity, despite active proliferation of the administered probiotic strains. Therefore, alteration of the healthy infant gut microbiota is not likely to be a prominent mechanism by which these specific probiotics works to exert beneficial effects on host health. NCT02180581 . Registered 30 June 2014.
机译:益生菌越来越多地用于预防和治疗一系列传染性,免疫相关性和胃肠道疾病。尽管如此,人们对益生菌推定作用背后的机理了解甚少。益生菌作用的建议模式之一是调节内源性肠道菌群,但是对成年人的益生菌干预研究未能显示出对肠道菌群组成的显着影响。已知幼儿的肠道菌群比成人的肠道菌群不稳定,并且对外界因素的反应更快。因此,益生菌干预对肠道菌群的潜在影响在生命早期可能更容易检测到。因此,我们调查了动物双歧杆菌亚种6个月安慰剂对照益生菌干预的效果。通过16S rRNA扩增子测序评估的乳酸菌(BB-12®)和鼠李糖乳杆菌(LGG®)在200多个丹麦婴儿中的肠道菌群组成和多样性(N = 290入组; N = 201所有被分析样品)。此外,我们通过使用特异性定量聚合酶链反应(qPCR)评估了益生菌的存在和增殖。与安慰剂相比,益生菌给药未显着改变肠道菌群的结构或多样性。在接受益生菌的儿童粪便样本中有91.3%检出了益生菌,在接受安慰剂的儿童中检出了1%。在六个月的干预后,未发现基线肠道菌群可预测益生菌在肠道中建立的能力。在益生菌组中,分别在44.7%和83.5%的参与者中检测到肠内LGG®和BB-12®菌株的增殖。对肠道菌群的亚分析仅包括检测到益生菌LGG®或BB-12®的生长的个体,并将其与安慰剂进行比较,结果发现群落结构或多样性没有差异。尽管所施用的益生菌菌株活跃繁殖,但在生命早期六个月的益生菌施用并未改变肠道菌群的结构或多样性。因此,健康婴儿肠道菌群的改变不太可能是这些特殊益生菌通过其对宿主健康产生有益作用的重要机制。 NCT02180581。 2014年6月30日注册。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号